References:
- Orbach D, Sarnacki S, Brisse HJ, Gauthier-Villars M, Jarreau PH,
Tsatsaris V, et al. Lancet Oncol. 2013 Dec;14(13)
- Sultan I, Casanova M, Al-Jumaily U, Meazza C, Rodriguez-Galindo C,
Ferrari A. Soft tissue sarcomas in the first year of life.
- Eur J Cancer. 2010 Sep; 46(13): 2449-56.von Mehren M, Lor Randall R,
DeLaney T, George S, Riedel R, Scheutze S, et al. NCCN Clinical
Practice Guidelines in Oncology (NCCN Guidelines®) Soft Tissue
Sarcoma. (2014;2.2014:126)
- Tran QN, Kim AC, Gottschalk AR, Wara WM, Phillips TL, O’Donnell RJ, et
al. Clinical outcomes of intraoperative radiation therapy for
extremity sarcomas. Sarcoma. 2006;2006(1):91671. Pubmed Central PMCID:
1557794, Epub (2006/10/17)
- Fernandez-Pineda
I,
Neel
MD,
Rao
BN. Current management of soft tissue sarcoma and Benign Tumors with
Local Aggresiveness
- Laskar, S., Pilar, A., Khanna, N., Puri, A., Gulia, A., Qureshi, S.,
Ramadwar, M. Interstitial brachytherapy for pediatric soft tissue
sarcoma: Evolving practice over three decades and long-term outcomes.
Pediatric Blood & Cancer (2018)
- Orbach D, Rey A, Oberlin O, et al. Soft tissue sarcoma or malignant
mesenchymal tumors in the first year of life: experience of the
International Society of Pediatric Oncology (SIOP) Malignant
Mesenchymal Tumor Committee. Journal of clinical oncology: official
journal of the American Society of Clinical Oncology 2005;23:4363-71.
- Koscielniak E, Harms D, Schmidt D, et al. Soft tissue sarcomas in
infants younger than 1 year of age: a report of the German Soft Tissue
Sarcoma Study Group (CWS-81). Medical and pediatric oncology
1989;17:105-10.
- Spunt SL, Million L, Chi YY, et al. A risk-based treatment strategy
for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than
30 years (ARST0332): a Children’s Oncology Group prospective study.
The Lancet Oncology 2020;21:145-61.